MARK NUGUID: Open Payments
NPI 1447785290 · TAMPA, FL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,727 in 74 payments from 16 companies in 2025. Trend: 2023 $819 · 2024 $711 · 2025 $1,727
Food & beverage: $1,647Education: $80
| Company | Payments | Amount |
|---|---|---|
| ViiV Healthcare Company | 12 | $300 |
| Astellas Pharma US Inc | 6 | $233 |
| Insmed, Inc. | 8 | $184 |
| Merck Sharp & Dohme LLC | 9 | $161 |
| Gilead Sciences, Inc. | 7 | $155 |
| La Jolla Pharmaceutical Company | 6 | $137 |
| Ferring Pharmaceuticals Inc. | 6 | $133 |
| ABBVIE INC. | 5 | $110 |
| Shionogi Inc | 4 | $69 |
| CSL Behring | 2 | $54 |
Products named: Arikayce, Cresemba, REBYOTA, CABENUVA, ZEVTERA, PIFELTRO, Fetroja, PREVYMIS.
Industry payments across FL — which companies pay providers there.
